Weight-loss: Repeat treatments with GI Dynamics' EndoBarrier may extend benefits
Patients re-implanted with GI Dynamics' EndoBarrier weight-loss device experience additional weight-loss and extended improvements in body mass levels and health factors associated with diabetes, according to a new study.
Patients who were re-implanted with GI Dynamics (ASX:GID) EndoBarrier intestinal liner experienced extended weight-loss and diabetes-risk improvements without additional complications, according to a new study.
A group of 19 patients who had previously undergone 1 year of EndoBarrier treatment underwent re-implantation, 14 of them for another 1-year period.
The patients lost more weight, lowered their body mass index ratings, reduced triglyceride levels and saw decreased levels of fasting blood glucose, a key blood sugar measure used to diagnose diabetes, according to a press release.